| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.54e-06 | 188 | 42 | 6 | GO:0005201 | |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix constituent secretion | 2.31e-05 | 4 | 41 | 2 | GO:0003332 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 2.31e-05 | 84 | 41 | 4 | GO:1903053 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 4.57e-05 | 490 | 41 | 7 | GO:0051347 | |
| GeneOntologyBiologicalProcess | endocardium morphogenesis | 8.04e-05 | 7 | 41 | 2 | GO:0003160 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process involved in morphogenesis | 8.04e-05 | 7 | 41 | 2 | GO:1902339 | |
| GeneOntologyBiologicalProcess | circulatory system development | OBSL1 REST PTPRB TNFRSF1A ANGPT1 ERAP1 NOTCH1 WNT7A SMYD2 DIPK2A EFEMP2 | 8.39e-05 | 1442 | 41 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 9.52e-05 | 748 | 41 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process involved in development | 1.07e-04 | 8 | 41 | 2 | GO:1904747 | |
| GeneOntologyBiologicalProcess | neuron projection development | 1.61e-04 | 1285 | 41 | 10 | GO:0031175 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 1.65e-04 | 810 | 41 | 8 | GO:0051338 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix constituent secretion | 1.72e-04 | 10 | 41 | 2 | GO:0003330 | |
| GeneOntologyBiologicalProcess | viral transcription | 2.08e-04 | 58 | 41 | 3 | GO:0019083 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion-dependent exocytosis | 2.10e-04 | 11 | 41 | 2 | GO:0045955 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.19e-04 | 59 | 41 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell myoblast differentiation | 2.51e-04 | 12 | 41 | 2 | GO:0060379 | |
| GeneOntologyBiologicalProcess | endocardium development | 2.97e-04 | 13 | 41 | 2 | GO:0003157 | |
| GeneOntologyBiologicalProcess | inner ear auditory receptor cell differentiation | 3.20e-04 | 67 | 41 | 3 | GO:0042491 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell development | 3.98e-04 | 15 | 41 | 2 | GO:0097084 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in morphogenesis | 3.98e-04 | 15 | 41 | 2 | GO:1902337 | |
| GeneOntologyBiologicalProcess | extracellular matrix constituent secretion | 3.98e-04 | 15 | 41 | 2 | GO:0070278 | |
| GeneOntologyBiologicalProcess | neuron development | 4.59e-04 | 1463 | 41 | 10 | GO:0048666 | |
| GeneOntologyBiologicalProcess | glomerulus development | 4.81e-04 | 77 | 41 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 5.00e-04 | 78 | 41 | 3 | GO:0035315 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in development | 5.14e-04 | 17 | 41 | 2 | GO:1904748 | |
| GeneOntologyBiologicalProcess | somatic stem cell division | 5.14e-04 | 17 | 41 | 2 | GO:0048103 | |
| GeneOntologyBiologicalProcess | vasculogenesis involved in coronary vascular morphogenesis | 5.78e-04 | 18 | 41 | 2 | GO:0060979 | |
| GeneOntologyBiologicalProcess | cardioblast differentiation | 5.78e-04 | 18 | 41 | 2 | GO:0010002 | |
| GeneOntologyBiologicalProcess | positive regulation of keratinocyte differentiation | 6.45e-04 | 19 | 41 | 2 | GO:0045618 | |
| GeneOntologyBiologicalProcess | heart development | 6.60e-04 | 757 | 41 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | 8.15e-04 | 1028 | 41 | 8 | GO:0043085 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 8.36e-04 | 93 | 41 | 3 | GO:0060415 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 8.67e-04 | 377 | 41 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 8.77e-04 | 378 | 41 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 8.88e-04 | 379 | 41 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 9.16e-04 | 96 | 41 | 3 | GO:0060113 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.03e-03 | 817 | 41 | 7 | GO:0048514 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 1.03e-03 | 24 | 41 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 1.09e-03 | 102 | 41 | 3 | GO:0048644 | |
| GeneOntologyBiologicalProcess | regulation of viral transcription | 1.12e-03 | 25 | 41 | 2 | GO:0046782 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.12e-03 | 25 | 41 | 2 | GO:0002483 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.15e-03 | 104 | 41 | 3 | GO:0042490 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.19e-03 | 405 | 41 | 5 | GO:0033674 | |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 1.22e-03 | 26 | 41 | 2 | GO:0060088 | |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix organization | 1.22e-03 | 26 | 41 | 2 | GO:1903054 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 1.22e-03 | 106 | 41 | 3 | GO:0051149 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.26e-03 | 410 | 41 | 5 | GO:0031589 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 1.29e-03 | 240 | 41 | 4 | GO:0070374 | |
| GeneOntologyBiologicalProcess | viral gene expression | 1.32e-03 | 109 | 41 | 3 | GO:0019080 | |
| GeneOntologyBiologicalProcess | striated muscle cell proliferation | 1.36e-03 | 110 | 41 | 3 | GO:0014855 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 1.41e-03 | 28 | 41 | 2 | GO:0051152 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermal cell differentiation | 1.41e-03 | 28 | 41 | 2 | GO:0045606 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 1.49e-03 | 870 | 41 | 7 | GO:0030855 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 1.62e-03 | 30 | 41 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.66e-03 | 118 | 41 | 3 | GO:0001570 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | 1.67e-03 | 1430 | 41 | 9 | GO:0044093 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 1.73e-03 | 31 | 41 | 2 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 1.73e-03 | 31 | 41 | 2 | GO:0061437 | |
| GeneOntologyBiologicalProcess | auditory receptor cell morphogenesis | 1.73e-03 | 31 | 41 | 2 | GO:0002093 | |
| GeneOntologyBiologicalProcess | negative regulation of cytokine production | 1.79e-03 | 444 | 41 | 5 | GO:0001818 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in morphogenesis | 1.84e-03 | 32 | 41 | 2 | GO:0060561 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 1.84e-03 | 32 | 41 | 2 | GO:1903306 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.84e-03 | 32 | 41 | 2 | GO:0019883 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 1.96e-03 | 33 | 41 | 2 | GO:0045684 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 1.96e-03 | 33 | 41 | 2 | GO:2000737 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 1.96e-03 | 269 | 41 | 4 | GO:0002064 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 2.08e-03 | 34 | 41 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | epidermis development | 2.11e-03 | 461 | 41 | 5 | GO:0008544 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.13e-03 | 1194 | 41 | 8 | GO:0000902 | |
| GeneOntologyBiologicalProcess | blood vessel development | 2.16e-03 | 929 | 41 | 7 | GO:0001568 | |
| GeneOntologyBiologicalProcess | synapse organization | 2.19e-03 | 685 | 41 | 6 | GO:0050808 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 2.20e-03 | 35 | 41 | 2 | GO:0035116 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 2.21e-03 | 686 | 41 | 6 | GO:0043549 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.06e-06 | 656 | 43 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.21e-06 | 658 | 43 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | basement membrane | 1.14e-04 | 122 | 43 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.87e-04 | 155 | 43 | 4 | GO:0098685 | |
| GeneOntologyCellularComponent | microfibril | 3.18e-04 | 13 | 43 | 2 | GO:0001527 | |
| Domain | EGF-like_dom | 1.25e-06 | 249 | 42 | 7 | IPR000742 | |
| Domain | EGF | 1.34e-05 | 235 | 42 | 6 | SM00181 | |
| Domain | EGF_1 | 2.12e-05 | 255 | 42 | 6 | PS00022 | |
| Domain | EGF-like_CS | 2.42e-05 | 261 | 42 | 6 | IPR013032 | |
| Domain | Growth_fac_rcpt_ | 2.53e-05 | 156 | 42 | 5 | IPR009030 | |
| Domain | EGF_2 | 2.63e-05 | 265 | 42 | 6 | PS01186 | |
| Domain | EGF_CA | 4.10e-05 | 86 | 42 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 6.58e-05 | 97 | 42 | 4 | IPR018097 | |
| Domain | EGF_CA | 7.12e-05 | 99 | 42 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.41e-05 | 100 | 42 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.29e-05 | 106 | 42 | 4 | IPR000152 | |
| Domain | EGF_CA | 1.60e-04 | 122 | 42 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.70e-04 | 124 | 42 | 4 | IPR001881 | |
| Domain | EGF_3 | 1.76e-04 | 235 | 42 | 5 | PS50026 | |
| Domain | EGF | 1.81e-04 | 126 | 42 | 4 | PF00008 | |
| Domain | TIL | 3.21e-04 | 12 | 42 | 2 | PF01826 | |
| Domain | C8 | 3.21e-04 | 12 | 42 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 3.79e-04 | 13 | 42 | 2 | IPR014853 | |
| Domain | C8 | 3.79e-04 | 13 | 42 | 2 | SM00832 | |
| Domain | TIL_dom | 4.42e-04 | 14 | 42 | 2 | IPR002919 | |
| Domain | LAMININ_NTER | 5.81e-04 | 16 | 42 | 2 | PS51117 | |
| Domain | VWFD | 5.81e-04 | 16 | 42 | 2 | PS51233 | |
| Domain | Laminin_N | 5.81e-04 | 16 | 42 | 2 | PF00055 | |
| Domain | VWD | 5.81e-04 | 16 | 42 | 2 | SM00216 | |
| Domain | VWF_type-D | 5.81e-04 | 16 | 42 | 2 | IPR001846 | |
| Domain | Laminin_N | 5.81e-04 | 16 | 42 | 2 | IPR008211 | |
| Domain | VWD | 5.81e-04 | 16 | 42 | 2 | PF00094 | |
| Domain | LamNT | 5.81e-04 | 16 | 42 | 2 | SM00136 | |
| Domain | VWC_out | 8.24e-04 | 19 | 42 | 2 | SM00215 | |
| Domain | Ig_I-set | 8.59e-04 | 190 | 42 | 4 | IPR013098 | |
| Domain | I-set | 8.59e-04 | 190 | 42 | 4 | PF07679 | |
| Domain | cEGF | 1.55e-03 | 26 | 42 | 2 | IPR026823 | |
| Domain | cEGF | 1.55e-03 | 26 | 42 | 2 | PF12662 | |
| Domain | hEGF | 1.80e-03 | 28 | 42 | 2 | PF12661 | |
| Domain | IGc2 | 1.88e-03 | 235 | 42 | 4 | SM00408 | |
| Domain | Ig_sub2 | 1.88e-03 | 235 | 42 | 4 | IPR003598 | |
| Domain | EGF_LAM_2 | 2.06e-03 | 30 | 42 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 2.06e-03 | 30 | 42 | 2 | PS01248 | |
| Domain | Laminin_EGF | 2.80e-03 | 35 | 42 | 2 | PF00053 | |
| Domain | EGF_Lam | 2.80e-03 | 35 | 42 | 2 | SM00180 | |
| Domain | VWC | 3.30e-03 | 38 | 42 | 2 | SM00214 | |
| Domain | Laminin_EGF | 3.30e-03 | 38 | 42 | 2 | IPR002049 | |
| Domain | VWFC_2 | 3.30e-03 | 38 | 42 | 2 | PS50184 | |
| Domain | VWF_dom | 4.02e-03 | 42 | 42 | 2 | IPR001007 | |
| Domain | Ig-like_fold | 4.69e-03 | 706 | 42 | 6 | IPR013783 | |
| Domain | IG_LIKE | 4.69e-03 | 491 | 42 | 5 | PS50835 | |
| Domain | Ig-like_dom | 5.20e-03 | 503 | 42 | 5 | IPR007110 | |
| Domain | EGF_extracell | 8.05e-03 | 60 | 42 | 2 | IPR013111 | |
| Domain | EGF_2 | 8.05e-03 | 60 | 42 | 2 | PF07974 | |
| Pubmed | Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. | 1.49e-06 | 2 | 43 | 2 | 12189246 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 23993985 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 18445477 | ||
| Pubmed | An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. | 4.48e-06 | 3 | 43 | 2 | 12748171 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 32680471 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 7.58e-06 | 101 | 43 | 4 | 23382219 | |
| Pubmed | 8.54e-06 | 225 | 43 | 5 | 12168954 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 34663817 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 11163081 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 20036815 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 16968706 | ||
| Pubmed | Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. | 2.23e-05 | 6 | 43 | 2 | 21068102 | |
| Pubmed | TRIM8 OBSL1 RNF216 WDFY3 RAD54L2 R3HDM1 HLA-DRB1 SMYD2 EFEMP2 | 2.26e-05 | 1285 | 43 | 9 | 35914814 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 17418794 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 16141228 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 15457442 | ||
| Pubmed | Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP. | 4.16e-05 | 8 | 43 | 2 | 29358379 | |
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 18338763 | ||
| Pubmed | Complex genetic predisposition in adult and juvenile rheumatoid arthritis. | 5.35e-05 | 9 | 43 | 2 | 15018649 | |
| Pubmed | 5.45e-05 | 59 | 43 | 3 | 21421844 | ||
| Pubmed | 5.47e-05 | 167 | 43 | 4 | 22159717 | ||
| Pubmed | Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. | 6.68e-05 | 10 | 43 | 2 | 28489825 | |
| Pubmed | Notch-Tnf signalling is required for development and homeostasis of arterial valves. | 8.15e-05 | 11 | 43 | 2 | 26491108 | |
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 20346184 | ||
| Pubmed | Multiple sclerosis susceptibility alleles in African Americans. | 1.15e-04 | 13 | 43 | 2 | 19865102 | |
| Pubmed | Opposing Effects of Growth and Differentiation Factors in Cell-Fate Specification. | 1.15e-04 | 13 | 43 | 2 | 31155355 | |
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 12441053 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 22797898 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 25401743 | ||
| Pubmed | The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. | 1.55e-04 | 15 | 43 | 2 | 15107403 | |
| Pubmed | Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart. | 1.55e-04 | 15 | 43 | 2 | 25072663 | |
| Pubmed | Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies. | 1.55e-04 | 15 | 43 | 2 | 23349640 | |
| Pubmed | 1.60e-04 | 417 | 43 | 5 | 19199708 | ||
| Pubmed | 2.01e-04 | 17 | 43 | 2 | 19879194 | ||
| Pubmed | 2.26e-04 | 18 | 43 | 2 | 16514057 | ||
| Pubmed | Chloride intracellular channel 4 is required for maturation of the cerebral collateral circulation. | 2.26e-04 | 18 | 43 | 2 | 26276819 | |
| Pubmed | 2.52e-04 | 19 | 43 | 2 | 19525953 | ||
| Pubmed | 2.52e-04 | 19 | 43 | 2 | 18206867 | ||
| Pubmed | A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. | 2.80e-04 | 20 | 43 | 2 | 12588999 | |
| Pubmed | LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. | 3.09e-04 | 21 | 43 | 2 | 17119023 | |
| Pubmed | 3.09e-04 | 21 | 43 | 2 | 26939553 | ||
| Pubmed | 3.09e-04 | 21 | 43 | 2 | 18617694 | ||
| Pubmed | Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior. | 4.05e-04 | 24 | 43 | 2 | 29086765 | |
| Pubmed | Continued expression of GATA3 is necessary for cochlear neurosensory development. | 4.05e-04 | 24 | 43 | 2 | 23614009 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 4.13e-04 | 283 | 43 | 4 | 18854154 | |
| Pubmed | 4.26e-04 | 118 | 43 | 3 | 21078624 | ||
| Pubmed | WD40 repeat and FYVE domain containing 3 is essential for cardiac development. | 4.40e-04 | 25 | 43 | 2 | 30428088 | |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 4.58e-04 | 121 | 43 | 3 | 31900314 | |
| Pubmed | 4.76e-04 | 26 | 43 | 2 | 20301347 | ||
| Pubmed | 4.76e-04 | 26 | 43 | 2 | 24742657 | ||
| Pubmed | SCAP knockout in SM22α-Cre mice induces defective angiogenesis in the placental labyrinth. | 5.14e-04 | 27 | 43 | 2 | 33227706 | |
| Pubmed | Extra-embryonic vasculature development is regulated by the transcription factor HAND1. | 5.53e-04 | 28 | 43 | 2 | 15073150 | |
| Pubmed | 5.93e-04 | 29 | 43 | 2 | 17573777 | ||
| Pubmed | Dosage-dependent requirement for mouse Vezf1 in vascular system development. | 5.93e-04 | 29 | 43 | 2 | 15882861 | |
| Pubmed | SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. | 5.93e-04 | 29 | 43 | 2 | 17928865 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 6.18e-04 | 560 | 43 | 5 | 21653829 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 6.25e-04 | 1201 | 43 | 7 | 35696571 | |
| Pubmed | 6.35e-04 | 30 | 43 | 2 | 20301299 | ||
| Pubmed | 6.35e-04 | 30 | 43 | 2 | 23349620 | ||
| Pubmed | Nkx2-5 regulates cardiac growth through modulation of Wnt signaling by R-spondin3. | 6.79e-04 | 31 | 43 | 2 | 25053429 | |
| Pubmed | 6.79e-04 | 31 | 43 | 2 | 22925884 | ||
| Pubmed | 8.17e-04 | 34 | 43 | 2 | 26411367 | ||
| Pubmed | 9.67e-04 | 37 | 43 | 2 | 7584028 | ||
| Pubmed | 9.67e-04 | 37 | 43 | 2 | 27631609 | ||
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 1.07e-03 | 162 | 43 | 3 | 16502470 | |
| Pubmed | 1.11e-03 | 164 | 43 | 3 | 32409323 | ||
| Pubmed | 1.13e-03 | 40 | 43 | 2 | 27068110 | ||
| Pubmed | 1.19e-03 | 41 | 43 | 2 | 22675208 | ||
| Cytoband | 2q35 | 2.64e-03 | 79 | 44 | 2 | 2q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 3.47e-03 | 316 | 44 | 3 | chr3p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 3.76e-03 | 325 | 44 | 3 | chr9q34 | |
| GeneFamily | Fibulins | 8.44e-05 | 8 | 32 | 2 | 556 | |
| GeneFamily | Immunoglobulin like domain containing | 3.58e-04 | 193 | 32 | 4 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.84e-03 | 161 | 32 | 3 | 593 | |
| Coexpression | NABA_CORE_MATRISOME | 3.57e-07 | 275 | 44 | 7 | M5884 | |
| Coexpression | NABA_MATRISOME | COL4A6 LAMB2 MUC5B NTNG2 ANGPT1 HMCN2 TECTA FBN3 WNT7A EFEMP2 ZFP91 | 7.33e-07 | 1026 | 44 | 11 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.02e-07 | 196 | 44 | 6 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 5.74e-06 | 270 | 44 | 6 | MM17057 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.68e-05 | 191 | 44 | 5 | MM17059 | |
| Coexpression | NABA_MATRISOME | 3.74e-05 | 1008 | 44 | 9 | MM17056 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.18e-05 | 40 | 44 | 3 | M5887 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | 1.15e-04 | 905 | 44 | 8 | M40865 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 1.12e-06 | 187 | 44 | 5 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-06 | 197 | 44 | 5 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-06 | 197 | 44 | 5 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | facs-Kidney-nan-24m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 189 | 44 | 4 | 9d02a824bba59ea0660439f0510d843568e9d8c3 | |
| ToppCell | facs-Kidney-nan-24m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 189 | 44 | 4 | 5f8d4b61296c71b32362432a9ce4c1c3aaeb278d | |
| ToppCell | facs-Kidney-nan-24m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 189 | 44 | 4 | 18f82764b32496e54d1a604a531b261651c5e110 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 195 | 44 | 4 | 37d22a6448db1f83d098018fbb75a6dd8d9be302 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 195 | 44 | 4 | 37592b7ad912b381b1edc77f4032983f26e0aa5b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 196 | 44 | 4 | a20a56d8997d6db2a10046c8801c619a379de83c | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 4.22e-05 | 197 | 44 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 4.22e-05 | 197 | 44 | 4 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 4.22e-05 | 197 | 44 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.30e-05 | 198 | 44 | 4 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; PC3; HT_HG-U133A | 2.28e-06 | 200 | 44 | 6 | 6333_DN | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.89e-05 | 186 | 44 | 5 | 6675_UP | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.54e-05 | 194 | 44 | 5 | 4422_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 3.62e-05 | 195 | 44 | 5 | 2122_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.81e-05 | 197 | 44 | 5 | 3848_DN | |
| Drug | Azapropazone [13539-59-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.90e-05 | 198 | 44 | 5 | 6522_UP | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.99e-05 | 199 | 44 | 5 | 4831_DN | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 3.99e-05 | 199 | 44 | 5 | 5384_UP | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; PC3; HT_HG-U133A | 3.99e-05 | 199 | 44 | 5 | 6305_DN | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.13e-05 | 95 | 43 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.74e-05 | 106 | 43 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | endometrial cancer (is_marker_for) | 1.83e-05 | 35 | 43 | 3 | DOID:1380 (is_marker_for) | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.02e-05 | 110 | 43 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.02e-05 | 110 | 43 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.02e-05 | 110 | 43 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement | 2.07e-05 | 5 | 43 | 2 | EFO_0800407 | |
| Disease | allergic bronchopulmonary aspergillosis (is_implicated_in) | 3.10e-05 | 6 | 43 | 2 | DOID:13166 (is_implicated_in) | |
| Disease | dihomo-linolenate 20:3n3 or n6 measurement | 3.10e-05 | 6 | 43 | 2 | EFO_0021046 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6) measurement | 3.10e-05 | 6 | 43 | 2 | EFO_0800390 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) measurement | 3.10e-05 | 6 | 43 | 2 | EFO_0800434 | |
| Disease | very low density lipoprotein particle size measurement | 4.25e-05 | 133 | 43 | 4 | EFO_0008594 | |
| Disease | fatty acid desaturase enzyme activity measurement | 5.78e-05 | 8 | 43 | 2 | EFO_0009791 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 7.42e-05 | 9 | 43 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 7.42e-05 | 9 | 43 | 2 | OBA_2045130 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement | 7.42e-05 | 9 | 43 | 2 | EFO_0800271 | |
| Disease | triglycerides to total lipids in small LDL percentage | 8.85e-05 | 59 | 43 | 3 | EFO_0022337 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 9.27e-05 | 10 | 43 | 2 | OBA_2045075 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 9.27e-05 | 315 | 43 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.01e-04 | 321 | 43 | 5 | EFO_0004612, EFO_0004639 | |
| Disease | high density lipoprotein particle size measurement | 1.10e-04 | 170 | 43 | 4 | EFO_0008592 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.15e-04 | 330 | 43 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | triglycerides to phosphoglycerides ratio | 1.35e-04 | 68 | 43 | 3 | EFO_0022327 | |
| Disease | ovarian cancer (is_marker_for) | 1.35e-04 | 68 | 43 | 3 | DOID:2394 (is_marker_for) | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 1.36e-04 | 12 | 43 | 2 | OBA_2045152 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:3) in blood serum | 1.36e-04 | 12 | 43 | 2 | OBA_2045115 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 1.36e-04 | 12 | 43 | 2 | OBA_2045157 | |
| Disease | temporal arteritis | 1.36e-04 | 12 | 43 | 2 | EFO_1001209 | |
| Disease | uveitis (is_implicated_in) | 1.60e-04 | 13 | 43 | 2 | DOID:13141 (is_implicated_in) | |
| Disease | phosphatidylcholine 40:7 measurement | 1.60e-04 | 13 | 43 | 2 | EFO_0021477 | |
| Disease | triglycerides to total lipids in small HDL percentage | 1.60e-04 | 72 | 43 | 3 | EFO_0022336 | |
| Disease | phospholipids in large HDL measurement | 1.67e-04 | 73 | 43 | 3 | EFO_0022190 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 1.87e-04 | 14 | 43 | 2 | EFO_0022085 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.03e-04 | 78 | 43 | 3 | EFO_0022187 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.06e-04 | 200 | 43 | 4 | EFO_0004611, EFO_0020945 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.30e-04 | 206 | 43 | 4 | EFO_0004612, EFO_0020947 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 2.46e-04 | 16 | 43 | 2 | OBA_2045093 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.71e-04 | 86 | 43 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | Seizures | 2.85e-04 | 218 | 43 | 4 | C0036572 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 3.13e-04 | 18 | 43 | 2 | OBA_2045065 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.16e-04 | 224 | 43 | 4 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.16e-04 | 224 | 43 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.75e-04 | 96 | 43 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 3.88e-04 | 20 | 43 | 2 | OBA_2045071 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.04e-04 | 239 | 43 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | fatty acid measurement | 4.17e-04 | 436 | 43 | 5 | EFO_0005110 | |
| Disease | Immunosuppressant use measurement | 4.28e-04 | 21 | 43 | 2 | EFO_0009934 | |
| Disease | Vitiligo | 4.35e-04 | 101 | 43 | 3 | EFO_0004208 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 5.43e-04 | 109 | 43 | 3 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | Myasthenic Syndromes, Congenital | 5.61e-04 | 24 | 43 | 2 | C0751882 | |
| Disease | lymphoma | 5.61e-04 | 24 | 43 | 2 | EFO_0000574 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.88e-04 | 264 | 43 | 4 | EFO_0008317, EFO_0020944 | |
| Disease | alpha-linolenic acid measurement | 6.09e-04 | 25 | 43 | 2 | EFO_0007759 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 6.85e-04 | 118 | 43 | 3 | EFO_0010119 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 6.94e-04 | 276 | 43 | 4 | EFO_0004612, EFO_0020943 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 7.36e-04 | 121 | 43 | 3 | EFO_0008595, EFO_0020943 | |
| Disease | phosphatidylcholine 38:4 measurement | 7.65e-04 | 28 | 43 | 2 | EFO_0010386 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 7.65e-04 | 28 | 43 | 2 | OBA_2045139 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 8.21e-04 | 29 | 43 | 2 | cv:C5779548 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 8.47e-04 | 127 | 43 | 3 | EFO_0008595, EFO_0020947 | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 9.39e-04 | 31 | 43 | 2 | OBA_2045198 | |
| Disease | Global developmental delay | 9.68e-04 | 133 | 43 | 3 | C0557874 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 9.81e-04 | 303 | 43 | 4 | EFO_0004612, EFO_0020945 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.03e-03 | 307 | 43 | 4 | EFO_0004612, EFO_0020946 | |
| Disease | phosphatidylcholine 38:5 measurement | 1.06e-03 | 33 | 43 | 2 | EFO_0010387 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.06e-03 | 33 | 43 | 2 | DOID:10003 (is_implicated_in) | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.09e-03 | 312 | 43 | 4 | EFO_0004612, EFO_0010351 | |
| Disease | left ventricular mass index | 1.13e-03 | 34 | 43 | 2 | EFO_0009290 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.13e-03 | 315 | 43 | 4 | EFO_0004574, EFO_0004612 | |
| Disease | cholesteryl ester 16:0 measurement | 1.27e-03 | 36 | 43 | 2 | EFO_0010341 | |
| Disease | triglyceride measurement, phospholipid measurement | 1.27e-03 | 146 | 43 | 3 | EFO_0004530, EFO_0004639 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.37e-03 | 150 | 43 | 3 | EFO_0004611, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YCNINEVCHYARRND | 1526 | Q14031 | |
| AERYAAACGVNYIHQ | 241 | Q9BXX2 | |
| RRYNRIQHGQCAYTF | 31 | Q15389 | |
| CHDAQAVCRVYRYGQ | 841 | Q9Y4B4 | |
| YRCECNVGYTQDVRG | 431 | Q75N90 | |
| AYCQVRYLCSHLRGN | 371 | Q6ZP65 | |
| CFNYEIRVFCCNYGH | 2956 | Q9HC84 | |
| CFNYEIRVFCCNYGH | 3656 | Q9HC84 | |
| YYCDHQRGQKCVEFS | 856 | Q15032 | |
| VYVCRARNAAGEAYA | 81 | O75147 | |
| IRCDRCGYNTNRYDH | 216 | Q13127 | |
| CQYVYLHQCVRDVLR | 1951 | P23467 | |
| YRCHCQAGYSGRNCE | 891 | P46531 | |
| ACAYQCHNLQGSYRC | 4766 | Q8NDA2 | |
| CVHNYQPCVQRAEGY | 736 | Q9NZ08 | |
| CRIFRYENGCAYFHE | 126 | Q6P996 | |
| CRIFRYENGCAYFHE | 126 | Q6P474 | |
| DEYSQQIVCHCRAGY | 946 | P55268 | |
| IRSGYHYVCLRNEAN | 816 | Q01970 | |
| VSARHYGNYTCRAAN | 281 | A6NGN9 | |
| GYRRDVHQVACYSCT | 506 | Q53GT1 | |
| CARATVDHNYYAVCQ | 351 | Q8NDZ4 | |
| RAAVDTYCRHNYGVV | 101 | P01911 | |
| YRGRDCRNNVHYLND | 1371 | Q05BV3 | |
| DECRYRYCQHRCVNL | 166 | O95967 | |
| RGQHCQHCRLGYYRN | 381 | Q96CW9 | |
| ENVYSYACQNHICRN | 196 | Q9BQQ7 | |
| FHTQVNRTYCCGTYR | 456 | Q5VWQ0 | |
| GCCYRVNNSLDHEYQ | 71 | Q9UL19 | |
| RGVAVHFAVCYRCAQ | 321 | B7ZBB8 | |
| YLCRVSINGYDHFCQ | 701 | Q9NWF9 | |
| CHGVVNVTAYYRTCL | 926 | O75443 | |
| YQCHQCGNAFRRKSY | 281 | Q8N184 | |
| CQNCYYNLQHERGSE | 3506 | Q8IZQ1 | |
| CYRNGVCYHQRPDEN | 61 | Q8WZ59 | |
| YCRRFCQVVEDYAGR | 56 | Q8IZM8 | |
| LMCCGRGYNTHQYAR | 306 | O00755 | |
| QLRNYCHSCNRVGYF | 436 | Q5GH77 | |
| HTDQRDYICEYCARA | 366 | Q96JP5 | |
| GDLRYQCNQCSYRCH | 481 | P52746 | |
| YVLTVNERGNHCEYC | 41 | Q9NRG4 | |
| YRLYHCEAEQVAVCQ | 151 | Q9BZR9 | |
| RDTVCGCRKNQYRHY | 121 | P19438 | |
| CRQCVEAYQDYDHHA | 261 | B1AL88 | |
| YCAQYRGEVCNAVLA | 316 | O15146 |